We partner with academic and industry organizations in the US and all over the world to help patients find diagnoses, therapies, and cures. Some of the organizations we work with are listed below:
Columbia University’s Medical Center is a world leader in scientific research, health and medical education, and patient care. Its core mission includes educating and training future generations of health care professionals and conducting basic research with the ultimate goal of translating discoveries into new techniques for fighting disease and improving health. The Center for Human Genetics at Columbia includes cutting-edge research in genomics and molecular diagnostics, as well as clinical practice and therapy.
Duke is proud to be an inclusive community of outstanding learners, investigators and clinicians where traditional barriers are low, interdisciplinary collaboration is embraced, and great ideas accelerate translation of fundamental scientific discoveries to improve human health around the globe. 21st Century medicine and medical education are evolving rapidly. Medicine is becoming “personalized” – focused on understanding and promoting the health of individual patients, rather than formulaic treatment of a list of diagnoses. Duke is proud to be at the forefront of this transformation.
In 1970 Emory University established Emory Genetics Laboratory (EGL) as an academic, not-for-profit organization, associated with the prestigious Emory University School of Medicine, Department of Human Genetics. Since its inception, EGL has served as the only comprehensive provider of clinical and laboratory genetic services in Georgia. EGL currently employs greater than 100 staff members and is led by a highly experienced and knowledgeable team of laboratory directors, who are pioneers in the field of human genetics. EGL offers greater than 800 tests, including next generation sequencing for large gene panels and clinical exome sequencing, in CLIA-/CAP-accredited setting. The unique combination of a well-established basic research faculty, along with the comprehensive clinical genetics division, places EGL at the forefront of contemporary translational research and predictive health.
InVitae sequences, analyzes and interprets every requisition in-house via their CLIA-certified genetic testing lab. InVitae performs targeted sequencing of genes plus extragenic variants for all conditions in their test menu. All exons, intron-exon boundaries, and non-coding regions containing known clinical variants are sequenced using next generation sequencing. Their custom variant interpretation identifies known and novel substitutions, insertions, and deletions, including those in traditionally hard to assay sites. Following sequencing and analysis, their clinical team reviews and interprets results in the context of the clinical information provided in the ordering process.
Parabase Genomics uses next-generation sequencing technologies including genome, exome and targeted panels to help families struggling for a diagnosis. This testing is done in a CLIA accredited lab that provides clinical interpretation of the sequence information and confirmation of disease causing variants. They have a team of innovators with expertise in genomics, pediatrics, and computational biology committed to improving the lives of children with genetic diseases.
The Scripps Research Institute (TSRI), one of the world’s largest, private, non-profit research organizations, stands at the forefront of basic biomedical science, a vital segment of medical research that seeks to comprehend the most fundamental processes of life. Over the last decades, the institute has established a lengthy track record of major contributions to the betterment of health and the human condition.
At Stanford Medicine, world-renowned scientists are at the forefront of an immense undertaking to advance the understanding and care of human health. Researchers across disciplines delve into unsolved problems in the basic and clinical sciences to gain insight into the building blocks of life. At the same time, Stanford is a place where discoveries find real-life application, as researchers and clinicians work together to move the most promising findings into improved diagnostic, treatment and prevention strategies. Translating pioneering medical research into quality patient care defines Stanford Hospital & Clinics and Lucile Packard Children’s Hospital. It is also the leading reason why both hospitals are consistently ranked among the best in the U.S. and internationally recognized for advanced care of both adult and pediatric patients. Stanford Hospital & Clinics and Packard Children’s benefit from cutting-edge medical discoveries and innovations emanating from the Stanford University School of Medicine, one of the premiere research institutions in the world. Together, Stanford Hospital & Clinics and Packard Children’s provide the highest quality clinical treatment and care by a staff committed to a single cause – the patient.
For more than half a century, UCLA Health System has provided the best in healthcare and the latest in medical technology to the people of Los Angeles and throughout the world. Comprised of Ronald Reagan UCLA Medical Center, UCLA Medical Center, Santa Monica, Resnick Neuropsychiatric Hospital at UCLA, Mattel Children’s Hospital UCLA, and the UCLA Medical Group with its wide-reaching system of primary-care and specialty-care offices throughout the region, UCLA Health System is among the most comprehensive and advanced healthcare systems in the world.
UW Medicine’s mission is to improve the health of the public by advancing medical knowledge, providing outstanding primary and specialty care to the people of the region, and preparing tomorrow™s physicians, scientists and other health professionals. UW School of Medicine has been ranked as the No. 1 primary-care medical school in the country since 1994. UW faculty members have been responsible for many basic science and technological advances in medicine. UW Medicine researchers are international leaders in genome sciences – contributing to the revolution in next-generation DNA sequencing technology and spearheading identification of candidate genes in rare diseases, such as Miller and Kabuki Syndromes.
Washington University School of Medicine is a leader in improving human health throughout the world. As noted leaders in patient care, research and education, our outstanding faculty members have contributed many discoveries and innovations to the field of science since the founding of the School of Medicine in 1891. With one of only three NIH funded large-scale sequencing centers in the US, Washington University is helping to lead the way in high-speed, comprehensive genomics and has played a vital role in the field of genome sequencing.
Founded in 1810, the Yale School of Medicine is a world-renowned center for biomedical research, education and advanced health care. Researchers at Yale have lead the field of human genetics and have identified more than 40 human disease genes. These include key genes and pathways that are critical to the risk of heart attack, hypertension, osteoporosis, stroke, as well as many rare or orphan diseases. These studies have provided new diagnostic and therapeutic approaches to these diseases, which affect more than one billion people worldwide.